Search
for
Sort by
Research 331–360 of 777
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Alopecia Areata: An Update on Treatment Options for Children
- Baricitinib for the Treatment of Alopecia Areata
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Biologics in the management of childhood atopic dermatitis
- Review of Promising Off-Label Use of Deucravacitinib
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- USE OF RITLECITINIB FOR THE TREATMENT OF ALOPECIA AREATA